Literature DB >> 11966703

Merkel cell carcinoma in a black human immunodeficiency virus-infected patient.

E Matichard1, Vincent Descamps, M Grossin, R Genin, E Bouvet, B Crickx.   

Abstract

Merkel cell carcinoma (MCC) is a rare malignant tumour that develops in sun-exposed areas in immunocompromised patients (chronic lymphocytic leukaemia, transplant recipients) older than 50 years. We report MCC in a young black woman with human immunodeficiency virus (HIV) infection. A 2-cm binodular violaceous lesion developed on her left ear lobe. Extensive work-up, including computed tomographic scans of the neck, chest, abdomen and pelvis, octreotide scan and sentinel node biopsy, did not demonstrate any metastasis. A wide excision was performed and the patient remained free of disease after 9 months. This case is the fourth observation of MCC in an HIV-infected patient.

Entities:  

Mesh:

Year:  2002        PMID: 11966703     DOI: 10.1046/j.1365-2133.2002.04592.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  5 in total

1.  Merkel cell carcinoma associated with HIV: review of 14 patients.

Authors:  Leonid Izikson; Erika Nornhold; Jayasri G Iyer; Paul Nghiem; Nathalie C Zeitouni
Journal:  AIDS       Date:  2011-01-02       Impact factor: 4.177

Review 2.  A technological update of molecular diagnostics for infectious diseases.

Authors:  Yu-Tsueng Liu
Journal:  Infect Disord Drug Targets       Date:  2008-09

Review 3.  Merkel cell carcinoma: a systematic review of ENT presentations.

Authors:  Federico Maria Gioacchini; Valentina Postacchini; Oriana Simonetti; Annamaria Offidani; Giuseppe Magliulo; Massimo Re
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-11-29       Impact factor: 2.503

4.  Merkel cell carcinoma.

Authors:  Virve Koljonen
Journal:  World J Surg Oncol       Date:  2006-02-08       Impact factor: 2.754

5.  Merkel cell carcinoma in immunosuppressed patients.

Authors:  Janice E Ma; Jerry D Brewer
Journal:  Cancers (Basel)       Date:  2014-06-27       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.